Biotech Archives - Insider Financial

Cerebain Biotech Corp (OTCMKTS:CBBT) A High Risk/Reward Play

After two years of underperformance, Cerebain Biotech Corp (OTCMKTS:CBBT) finds itself flirting with all-time lows having shed more than 80% in market...

517

Better Days Ahead For Innovation Pharmaceuticals Inc (OTCMKTS:IPIX)

Innovation Pharmaceuticals Inc (OTCMKTS:IPIX) embarking on an international expansion drive, for its lead candidate drug, could the spark that will fuel a...

432

CytoDyn Inc (OTCMKTS:CYDY) Huge Potential, Poor Execution

CytoDyn Inc (OYCMKTS:CYDY) is a name that we have covered quite a bit in the past here at Insider Financial. The company’s...

792

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Selloff Showing Signs of Exhaustion

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) has hit rock bottom after plunging to record lows, at the back of a ferocious sell-off. With...

405

Elite Pharmaceuticals Inc (OTCMKTS:ELTP) Trend Reversal In Play

Elite Pharmaceuticals Inc (OTCMKTS:ELTP) is still trading at a discount even on strengthening its pipeline of generic drugs. The company is fresh...

560

Biocept Inc (NASDAQ:BIOC) Looks To Have Bottomed

Following a year of bearish outlook on the company’s share price, Biocept Inc (NASDAQ:BIOC) is currently basking in the glory of their...

460

Microbot Medical Inc (NASDAQ:MBOT) Squeezes The Shorts

Microbot Medical Inc (NASDAQ:MBOT) really squeezed the shorts this week. It’s been a while since we’ve seen such a short squeeze. The last...

592

What Next For Immune Pharmaceuticals Inc (OTCMKTS:IMNP) After 90% Price Implosion?

A 90% plus price implosion attests to Immune Pharmaceuticals Inc (OTCMKTS:IMNP) underperformance over the past year. The stock is currently languishing at...